Zelgor Abiraterone Acetate 250mg Tablets

About Zelgor Abiraterone Acetate 250mg Tablets

Abiraterone acetate, the active ingredient in Zelgor (Abiraterone Acetate) 250mg Tablets, is used to treat metastatic castration-resistant prostate cancer (mCRPC) in adult males. An androgen biosynthesis inhibitor, such as abiraterone acetate, prevents the manufacture of androgens (male hormones), which are necessary for the proliferation of prostate cancer cells. In conjunction with prednisone or prednisolone, Zelgor is prescribed. Zelgor reduces prostate cancer growth and improves patient outcomes by preventing androgen production. Patients who have undergone hormone therapy and displayed disease progression are treated with it. For the management of probable side effects and to maximise therapeutic benefits, regular medical monitoring is crucial during therapy.

Zelgor (abiraterone acetate) 250mg Tablets' Features and Advantages:

Features:

1. Abiraterone Acetate, an inhibitor of tes tos tero ne production, is the active component in Zelgor tablets.

2. Treatment for Metastatic Castration-Resistant Prostate Cancer (mCRPC) Zelgor is recommended for the treatment of adult males with metastatic castration-resistant prostate cancer.

3. Hormone Therapy Resistance: It is applied to patients who have already had androgen deprivation therapy (hormone therapy) but have demonstrated disease progression.

4. Oral Administration: Since the tablets are administered orally, patients can administer them at home with ease.

5. Abiraterone acetate inhibits the production of androgens (male hormones), which are what give prostate cancer cells their energy.

6. Zelgor is administered in conjunction with prednisone or prednisolone to increase its effectiveness.

Benefits:

1. Control of prostate cancer: Zelgor significantly inhibits the spread of metastatic castration-resistant prostate cancer, improving patient outcomes and extending disease management.

2. Symptoms and general quality of life may be helped by Zelgor's ability to delay the progression of prostate cancer.

3. Increased Survival: The use of Zelgor has been linked to an increase in overall survival in mCRPC patients.

4. Delaying the Need for Chemotherapy: Zelgor may occasionally assist postpone the requirement for chemotherapy in the management of mCRPC.

5. Personalised Treatment: The use of Zelgor enables a treatment strategy depending on the characteristics of the cancer and the individual patient.

6. Zelgor is typically well tolerated and has minor side effects.

7. Zelgor 250mg tablets can frequently be provided as an outpatient procedure, minimising the requirement for protracted hospital stays.

8. Supportive Care: To manage side effects and enhance quality of life, patients receiving Zelgor therapy are given supportive care.

9. Research is still being done, and novel applications and drug combinations using abiraterone acetate are being investigated in the fight against prostate cancer, giving patients with mCRPC more alternatives for therapy.

Prior to beginning Zelgor medication, patients must discuss potential side effects and benefits with their doctor. To manage potential side effects and achieve the greatest results, regular medical monitoring is essential. Zelgor Abiraterone Acetate 250mg tablets must be used with care, and patients and their oncologists should work together to decide on the best course of treatment after taking into account each patient's unique situation and treatment objectives. To manage adverse effects and maximise therapy efficacy, patients should be regularly watched and given the proper care.

Tablets of 250mg Zelgor (Abiraterone Acetate) Uses:

Adult males with metastatic castration-resistant prostate cancer (mCRPC) are primarily treated with Zelgor tablets containing abiraterone acetate. For patients who have already undergone hormone therapy (androgen deprivation therapy) but have showed disease progression, it is administered in combination with prednisone or prednisolone.

Zelgor (Abiraterone Acetate) 250mg Tablets Side Effects:

Although Zelgor is generally well accepted, some people may experience some negative effects. Typical negative consequences could be:

1. Fatigue or Weakness
2. Hypertension (High Blood Pressure)
3. Fluid Retention or Edema
4. Hot Flashes
5. Joint or Muscle Pain
6. Nausea and Vomiting
7. Diarrhea or Constipation
8. Changes in Liver Function Tests
9. Cardiac Disorders (such as heart rhythm changes)
10. Adrenal Insufficiency (low levels of corticosteroid hormones)
11. Increased Risk of Fractures
12. Elevated Liver Enzymes
13. Urinary Tract Infection
14. Increased Risk of Infections
15. Changes in Blood Potassium Levels

Effective Cancer Support

Zelgor Abiraterone Acetate 250mg Tablets are designed to support effective cancer management, particularly for prostate cancer patients. With Abiraterone Acetate as the active ingredient, it works by inhibiting the production of androgens, hormones that can stimulate cancer growth. This targeted approach helps slow disease progression and is an important part of many treatment regimens.


Safe Handling and Storage

Proper storage is crucial for maintaining the efficacy of Zelgor tablets. Always keep the product at room temperature, around 25C, in a cool and dry place. Make sure the container is tightly closed and away from children. Adhering to these guidelines will help preserve the quality of the medication for its 2-year shelf life.